Antiplatelet treatment before, during, and after WEB procedure
| Before | During | After (1-Mo FU) | |
|---|---|---|---|
| No antiplatelet (No.) | 16/55 (29.1%) | 10/55 (18.2%) | 11/55 (20.0%) |
| Single antiplatelet (No.) | 15/55 (27.3%) | 16/55 (29.1%) | 31/55 (56.4%) |
| Dual antiplatelet (No.) | 24/55 (43.6%) | 29/55 (51.7%) | 13/55 (23.6%) |
Note:—FU indicates follow-up.